News | Magnetic Resonance Imaging (MRI) | September 11, 2015

Data collected from 10 different radiology centers to determine impact of interpretative variability on patient care

Spreemo, study, MRI, quality measures, variability, Hospital for Special Surgery, Thomas Jefferson University

September 11, 2015 — Value-driven health platform Spreemo has completed the first phase of a study to determine how interpretative variability in magnetic resonance imaging (MRI), a standard diagnostic test, can influence the course of a patient’s treatment. Conducted in partnership with Hospital for Special Surgery and Thomas Jefferson University, the study considers the interpretation of an MRI examination completed at different radiology centers, with the intent of countering the widespread misconception that diagnostic imaging is a commodity. The first phase involved examination of a test patient with low back and leg pain by 10 different imaging centers, in addition to two control exams performed at the onset and conclusion of the data collection period.

“An accurate diagnosis will make a critical difference in the trajectory of a patient’s care and ultimate outcome,” said Peter Moley, M.D., a physical medicine and rehabilitation specialist at Hospital for Special Surgery. "Selecting the right imaging center for diagnosing an acute or chronic spinal disorder is an integral step in achieving the best outcome for the patient, whereas a poorly performed and interpreted MRI may result in dire consequences.”

“From sub-specialization of the provider, to protocols, to equipment used, there are many variables that can impact the quality of an MRI,” added the study’s principal investigator, Richard Herzog, M.D., director of spinal imaging at Hospital for Special Surgery. “This study marks an important step toward a quantitative and empirical understanding of that variability and its impact on a patient’s care and outcome.”

The study is funded by The Spreemo Quality Research Institute, which launched in November 2014 in collaboration with employers and providers to measure the impact of quality standards and best practices on patient outcomes.

For more information: www.spreemo.com


Related Content

Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
News | Artificial Intelligence

July 26, 2024 — GE HealthCare and Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company, announced a strategic ...

Time July 26, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 26, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
Videos | Information Technology

Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and ...

Time July 25, 2024
arrow
News | Digital Pathology

July 24, 2024 — Proscia, a developer of artificial intelligence (AI)-enabled digital pathology solutions for precision ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
Subscribe Now